BOSEROLIMAB
UNII 576SCZ7V2P

Substance Identification & Data

This profile provides standardized clinical and technical data for Boserolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 576SCZ7V2P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2444297-08-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

576SCZ7V2P

CAS Registry Number

2444297-08-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BOSEROLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C172056

National Cancer Institute reference terminology for clinical and research data.

INN ID

11948

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-229

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Boserolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BOSEROLIMAB

Common Names & Synonyms

BOSEROLIMAB [INN]

BOSEROLIMAB [USAN]

GAMMA1 HEAVY CHAIN (1-446) (VH (HOMO SAPIENS IGHV1-2*02 (79.6%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT (8.8.9) (26- 33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230- 339), CH3 D12 (355), L14 (357) (340-444), CHS (445-446)) (117-446)), (219-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-213') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV4-59*01 (80.9%) -IGKJ4*01 (91.7%) S120>Q (104)/HOMO SAPIENS IGKV3-11*01 (80.0%) -IGKJ2*02 (100%), CDR-IMGT (5.3.9) (27- 31.49-51.88-96)) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213')); DIMER (225-225'':228-228'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD27 ANTIGEN) (HUMAN-MUS MUSCULUS CLONE 131A6 .GAMMA.1-CHAIN)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD27 (TNFRSF7, TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 7))

MK 5890 [WHO-DD]